Literature DB >> 15052360

UVA activated 8-MOP and chlorpromazine inhibit release of TNF-alpha by post-transcriptional regulation.

Agnieszka Wolnicka-Glubisz1, Tadeusz Sarna, Gabriele Klosner, Robert Knobler, Franz Trautinger.   

Abstract

There is evidence that regulation of inflammatory cytokines is among the immunomodulatory effects of photochemotherapy with 8-MOP and UVA. We have recently demonstrated that in the monocytoid cell line U937 incubation with 8-MOP and subsequent exposure to UVA is able to efficiently downregulate the release of TNF-alpha into the culture supernatant. Chlorpromazine, a well known photosensitising drug, was even more potent with regard to this effect. Based on these observations, in this study we further investigate the mechanisms of TNF-alpha inhibition by 8-MOP and CPZ photosensitization. For this purpose we determined intracellular protein levels and gene expression of TNF-alpha by western blot and quantitative real-time PCR, respectively. Our results indicate that the observed inhibition of TNF-alpha secretion after photochemotherapy is not due to downregulation of gene transcription but rather to a post-transcriptional mechanism. The observed decrease of intracellular TNF-alpha with CPZ and 8-MOP points to decreased protein synthesis or enhanced degradation. These findings demonstrate that posttranscriptional regulation of cytokine expression is a possible mechanism of action of photochemotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15052360     DOI: 10.1039/b302621c

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  2 in total

1.  [Advances in the molecular mechanisms of perineural invasion in salivary adenoid cystic carcinoma].

Authors:  Mei Zhang; Xin-Hua Liang; Ya-Ling Tang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-04-01

2.  Hypertrophic differentiation of mesenchymal stem cells is suppressed by xanthotoxin via the p38‑MAPK/HDAC4 pathway.

Authors:  Zhen Cao; Yun Bai; Chuan Liu; Ce Dou; Jianmei Li; Junyu Xiang; Chunrong Zhao; Zhao Xie; Qiang Xiang; Shiwu Dong
Journal:  Mol Med Rep       Date:  2017-06-29       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.